Cubist Systematic Strategies’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$28.7M Buy
154,700
+95,700
+162% +$16.4M 0.14% 175
2025
Q2
$9.01M Sell
59,000
-700
-1% -$108K 0.04% 667
2025
Q1
$9.9M Buy
59,700
+37,600
+170% +$5.88M 0.06% 487
2024
Q4
$3.2M Buy
22,100
+6,900
+45% +$1.07M 0.02% 1080
2024
Q3
$2.46M Sell
15,200
-7,600
-33% -$1.21M 0.02% 1305
2024
Q2
$3.33M Sell
22,800
-83,400
-79% -$12.4M 0.02% 1020
2024
Q1
$16.8M Sell
106,200
-45,100
-30% -$7.18M 0.1% 255
2023
Q4
$23.7M Buy
151,300
+10,500
+7% +$1.61M 0.15% 111
2023
Q3
$21.9M Buy
140,800
+54,100
+62% +$8.93M 0.16% 108
2023
Q2
$14.4M Sell
86,700
-27,900
-24% -$4.5M 0.1% 254
2023
Q1
$17.8M Sell
114,600
-24,300
-17% -$3.92M 0.11% 189
2022
Q4
$24.5M Sell
138,900
-500
-0.4% -$86.3K 0.14% 97
2022
Q3
$22.8M Buy
139,400
+25,900
+23% +$4.38M 0.13% 120
2022
Q2
$20.1M Buy
+113,500
New +$20.2M 0.12% 131

Other funds holding JNJ

Cubist Systematic Strategies's JNJ Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Johnson & Johnson (JNJ) in Q3 2025, closing a stake of 202,059 shares — an estimated $34.6M sold.

Cubist Systematic Strategies first reported a position in JNJ in Q2 2014 and held it in 42 quarters. The position peaked at $33.3M in Q1 2024. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Johnson & Johnson position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 202,059 Johnson & Johnson shares in Q3 2025, an estimated $34.6M.
  • Cubist Systematic Strategies first reported a position in Johnson & Johnson in Q2 2014 and held it in 42 quarters.
  • Cubist Systematic Strategies's Johnson & Johnson position peaked at $33.3M in Q1 2024.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.